Details of the Drug Reposition
General Information of This Drug (ID: DMBDPN2)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms | PF-00217830; 7-[4-(4-naphthalen-1-ylpiperazin-1-yl)butoxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one | |||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
![]() |
|||||
| 3D MOL | 2D MOL | |||||
Information on Drug Reposition of This Drug
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2 Discontinued in Phase 2 Indication(s)
|
|
||||||||||||||||||||||||||||||

